"This is a clinical guide to acute promyelocytic leukemia or APL, and it is the first book dedicated entirely to APL. Starting with an engaging historical account, the book provides a comprehensive overview of the clinical and basic aspects of APL, once regarded as the most fatal type of acute myeloid leukemia, but now considered the most curable. ... general practitioners and trainees also will find this book worth exploring ... ." (Ravi Salgia, Doody's Book Reviews, January 04, 2019)
1 History of APL
Laurent Degos
2 Molecular Targets of Treatment in APL
Ramy Rahmé, Cécile Esnault, Hugues de Thé
3 The Leukemic Stem Cell
Thalia Vlachou, Giulia De Conti, Anna Giulia Sanarico, Pier Giuseppe Pelicci
4 The Molecular Genetics of APL
Lourdes Mendez, Ming Chen, Pier Paolo Pandolfi
5 APL Coagulopathy
Anna Falanga, Laura Russo, Pau Montesinos
6 Early Death in APL
Sören Lehmann
7 Prognostic Factors in APL
Javier de la Serna, Pau Montesinos, Miguel A. Sanz
8 First-line therapy for APL: Chemotherapy-based approach
21 Management of Treatment-Related Complications in APL
Ombretta Annibali, Giuseppe Avvisati
Oussama Abla, MD
The Hospital for Sick Children and University of Toronto
Division of Hematology/Oncology
Toronto, ON
Canada
Francesco Lo-Coco, MD
Professor of Hematology
University of Tor Vergata
Rome
Italy
Miguel A. Sanz, MD
Centro de Investigación Biomédica en Red de Cáncer
Madrid
Spain
This book provides a comprehensive overview on the clinical issues and biology of acute promyelocytic leukemia (APL) and on the molecular mechanisms of targeted therapy with ATRA and ATO. The text covers major topics such as the pathophysiology of APL coagulopathy, biologic and clinical differences between children and adults with APL, and the role of minimal residual disease monitoring. Additionally, the book summarizes historical, current, and future treatment strategies in both adults and children, while highlighting the most recent therapeutic recommendations for relapsed disease and the evolving indications for autologous and allogeneic stem cell transplant. This volume also features chapters focusing on secondary APL and therapy, late effects, rare presentations such as APL in the elderly and during pregnancy, and rare APL variants that may represent therapeutic challenges.
Written by top experts in the field, Acute Promyelocytic Leukemia: A Clinical Guide is a valuable resource for clinicians and researchers who treat and investigate this disease in children and adults.